论文部分内容阅读
2013年7月17日,一年一度的行业盛会——第30届全国医药工业信息年会在上海隆重召开。本届年会以“创兴梦”为主题,把脉中国医药创新之路,探讨中国医药振兴之道,追梦中国医药长远未来。来自医药行业的各界专业人士共聚一堂,迸发行业未来发展新思维。与会人数更是突破千人,得到业内各方热切关注!中国医药企协统计工作委员会周斌主任为大会致开幕词,并对大会的“三十而立”寄予了鼓励和期望。对于医药行业而言,在战略性新兴产业发展定调、“大病医保”新政出台、破除“以药养医”改革试点、医保支付方式改革迈步、限抗令持续、新版GMP大限逼近、仿制药一致性评价起步等大环境下,2012年是一个名副其实的利好和负面因素交织、繁荣和危机并存的年份。
July 17, 2013, the annual industry event - the 30th annual National Pharmaceutical Industry Information Conference was held in Shanghai. The theme of this annual conference is “Chong Hing Dream”, taking the road of Chinese medicine innovation, exploring the road of rejuvenating Chinese medicine and catching the dream of Chinese medicine in the long run. Professionals from all walks of life of the pharmaceutical industry come together to burst the industry’s new thinking in the future. The number of participants is more than a thousand people, all sectors of the industry have been eagerly watched! CPPCC Working Committee Zhou Bin, director of the opening speech for the General Assembly, and the Assembly’s “thirty and set” placed the encouragement and expectations. For the pharmaceutical industry, in the strategic development of emerging industries fixed, “serious illness Medicare ” New Deal introduced, get rid of “medicine and medicine ” pilot reform, health care payment reform, the limit order continued, the new GMP deadline Approaching, generic drug evaluation of the start of such a large environment, 2012 is a veritable positive and negative factors intertwined, prosperous and crisis coexist.